Society guideline links: Neutropenic fever in children with cancer

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Neutropenic fever in adults with cancer".)

International

●International Pediatric Fever and Neutropenia Guideline Panel: Guideline for the management of fever and neutropenia in pediatric patients with cancer and hematopoietic cell transplantation recipients, update (2023)

●International Antibacterial Prophylaxis Guideline Panel: Guideline for antibacterial prophylaxis administration in pediatric cancer and hematopoietic stem cell transplantation (2020)

●International Society of Paediatric Oncology (SIOP) Paediatric Oncology in Developing Countries (PODC): Recommendations for supportive care of children with cancer in a low-income setting (2013)

Canada

●Choosing Wisely Canada: Don't start or prolong broad-spectrum antibiotic treatment unless clinically indicated (2022)

United States

●American Society of Clinical Oncology (ASCO): Clinical practice guideline recommendations for the use of WBC growth factors, update (2015)

●Infectious Diseases Society of America (IDSA): Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer, 2010 update (ARCHIVED; published 2011)

Europe

●European Society for Medical Oncology (ESMO): Clinical practice guidelines for management of febrile neutropaenia (2016)